Vanda Pharmaceuticals Inc. (LON:0LKB)

London flag London · Delayed Price · Currency is GBP · Price in USD
4.400
-0.120 (-2.65%)
At close: Feb 21, 2025
-0.18%
Market Cap 204.36M
Revenue (ttm) 158.77M
Net Income (ttm) -15.10M
Shares Out n/a
EPS (ttm) -0.26
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 338
Average Volume 4,025
Open 4.570
Previous Close 4.520
Day's Range 4.395 - 4.570
52-Week Range 2.816 - 5.390
Beta n/a
RSI 44.15
Earnings Date Feb 7, 2025

About Vanda Pharmaceuticals

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company’s marketed products include HETLIOZ to treat non-24-hour sleep-wake disorders; Fanapt (iloperidone) for the treatment of bipolar I disorder and Parkinson’s disease psychosis, as well as a long acting injectable (LAI) formulation to treat schizophrenia; and Ponvory for the treatment of psoriasis and ulcerative colitis. Its pipeline products include HETLIOZ (tasimelteon) ... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2002
Employees 368
Stock Exchange London Stock Exchange
Ticker Symbol 0LKB
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.